Results 241 to 250 of about 1,156,521 (411)
Coronary arteriovenous fistula with aneurysm of coronary sinus.
A Harris+2 more
openalex +1 more source
Malplacement of pacemaker catheters in the coronary sinus
John A. Meyer, Kay Millar
openalex +1 more source
Coronary Flow Impacts Aortic Leaflet Mechanics and Aortic Sinus Hemodynamics
Brandon L. Moore, L. Dasi
semanticscholar +1 more source
Abstract Purpose This study investigated whether previous COVID severity and vaccination affected subsequent elective postsurgical mortality and readmission rates at 30, 90 and 365 days. Methods 21 855 veterans were divided into two cohorts, a no‐COVID (NC) cohort of 19 338 patients and a previous COVID cohort of 2547 patients.
Henyah W. Dardir+4 more
wiley +1 more source
Idiopathic Coronary Sinus Thrombosis. [PDF]
Mok CH, Wong GL, So KC, Lee AP, Kam KK.
europepmc +1 more source
An enzyme histochemical study of human sinus node, coronary sinus, and mitral valve muscle. [PDF]
C Théry+3 more
openalex +1 more source
Coronary sinus thrombosis: insights from a comprehensive literature review. [PDF]
Yi C.
europepmc +1 more source
Congenital diverticulum of the heart arising from the coronary sinus. [PDF]
Elio Di Segni, A Siegal, M. Katzenstein
openalex +1 more source
High‐risk cardiac patients may benefit from timely temporary mechanical circulatory support (tMCS) implantation to provide perioperative hemodynamic stabilization and circulatory support, thus enabling them to undergo life‐saving thoracic surgery. CPB: cardiopulmonary bypass; IABP: intra‐aortic balloon pump; tMCS: temporary mechanical circulatory ...
Viviana Teresa Agosta+4 more
wiley +1 more source
A European update on transcatheter aortic valve implantation (TAVI) in the COVID era
A timely review of key Transcatheter Aortic Valve Implantation (TAVI) device trials delineated by surgical risk. Abstract Minimally invasive approaches for aortic valve replacement are now at the forefront of pathological aortic valve treatment. New trials show comparability of these devices to existing therapies, not only in high‐risk surgical cohorts
Ishan Antony+3 more
wiley +1 more source